Synthesis of azetidines via visible-light-mediated intermolecular [2+2] photocycloadditions.

Nat Chem

Willard Henry Dow Laboratory, Department of Chemistry, University of Michigan, Ann Arbor, MI, USA.

Published: October 2020


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Intermolecular [2+2] photocycloadditions represent a powerful method for the synthesis of highly strained, four-membered rings. Although this approach is commonly employed for the synthesis of oxetanes and cyclobutanes, the synthesis of azetidines via intermolecular aza Paternò-Büchi reactions remains highly underdeveloped. Here we report a visible-light-mediated intermolecular aza Paternò-Büchi reaction that utilizes the unique triplet state reactivity of oximes, specifically 2-isoxazoline-3-carboxylates. The reactivity of this class of oximes can be harnessed via the triplet energy transfer from a commercially available iridium photocatalyst and allows for [2+2] cycloaddition with a wide range of alkenes. This approach is characterized by its operational simplicity, mild conditions and broad scope, and allows for the synthesis of highly functionalized azetidines from readily available precursors. Importantly, the accessible azetidine products can be readily converted into free, unprotected azetidines, which represents a new approach to access these highly desirable synthetic targets.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41557-020-0541-1DOI Listing

Publication Analysis

Top Keywords

synthesis azetidines
8
visible-light-mediated intermolecular
8
intermolecular [2+2]
8
[2+2] photocycloadditions
8
synthesis highly
8
intermolecular aza
8
aza paternò-büchi
8
synthesis
5
azetidines visible-light-mediated
4
intermolecular
4

Similar Publications

Background: Chronic inflammation is a critical factor contributing to diabetes complications. Baricitinib inhibits JAK-STAT signalling, which can contribute to an anti-inflammatory effect. Similarly, metformin demonstrates anti-inflammatory properties by activating the AMPK-SIRT pathway and suppressing the NF-ᴋB signalling pathway.

View Article and Find Full Text PDF

Background: Anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis (MDA5-DM) is associated with severe outcomes, primarily due to rapidly progressive interstitial lung disease (RP-ILD), which is often refractory to standard therapies such as calcineurin inhibitors (e.g., tacrolimus) combined with cyclophosphamide (TC-Tx).

View Article and Find Full Text PDF

Sitosterolemia: Case Series of a Rare Genetic Disorder from India.

J Assoc Physicians India

July 2025

Consultant Clinical Hematologist, Department of Hemato-oncology, Kauvery Hospital, Trichy, Tamil Nadu, India.

Sitosterolemia is a rare inherited autosomal recessive disorder characterized by the accumulation of plant sterols in the blood, due to mutations in the ABCG5 and/or ABCG8 genes, which encode the protein sterolin. This condition can potentially lead to premature cardiac death due to atherosclerosis. We report a series of four patients with sitosterolemia who presented to us with nonspecific symptoms.

View Article and Find Full Text PDF

Fused-Linked and Spiro-Linked N-Containing Heterocycles.

Int J Mol Sci

August 2025

A. E. Favorsky Irkutsk Institute of Chemistry, Siberian Division of the Russian Academy of Sciences, 664033 Irkutsk, Russia.

Fused and spiro nitrogen-containing heterocycles play an important role as structural motifs in numerous biologically active natural products and pharmaceuticals. The review summarizes various approaches to the synthesis of three-, four-, five-, and six-membered fused and spiro heterocycles with one or two nitrogen atoms. The assembling of the titled compounds via cycloaddition, oxidative cyclization, intramolecular ring closure, and insertion of sextet intermediates-carbenes and nitrenes-is examined on a vast number of examples.

View Article and Find Full Text PDF

This study investigates the repurposing of BAF312 (Siponimod), an FDA-approved sphingosine-1-phosphate (S1P) receptor agonist for multiple sclerosis, as a dual-targeting therapeutic agent for glioma by inhibiting tumor growth and normalizing aberrant tumor vasculature. The clinical correlations between S1PR1/5 expression and glioma prognosis were analyzed using the GEPIA and HPA databases. The effects of BAF312 on tumor growth, cell cycle progression, apoptosis, and vascular remodeling were evaluated using orthotopic GL261 glioma models and glioma cell lines (U118MG, T98G, GL261).

View Article and Find Full Text PDF